Treatment of diabetes with copper binding compounds
First Claim
Patent Images
1. A method of treating a human for diabetes, the method comprising administering to said human a composition comprising a therapeutically effective amount of a pharmaceutically acceptable cupric binding agent.
2 Assignments
0 Petitions
Accused Products
Abstract
Novel methods of treating a patient for diseases, disorders, and conditions including diabetes mellitus, comprising administering, for example, copper binding compounds.
-
Citations
50 Claims
- 1. A method of treating a human for diabetes, the method comprising administering to said human a composition comprising a therapeutically effective amount of a pharmaceutically acceptable cupric binding agent.
-
6. A method of treating a human for diabetes, the method comprising administering to said human a composition comprising a therapeutically effective amount of a pharmaceutically acceptable oxidized copper binding agent.
- 11. A method of treating a human suffering from one or more conditions associated with one or more long-term complications of diabetes, the method comprising administering a composition comprising a cupric binding agent in an amount effective to ameliorate one or more of said conditions.
- 16. A method of preventing tissue damage in a human associated with diabetes mellitus, which comprises the prophylactic administration to a human of a therapeutically effective amount of a cupric binding agent.
- 21. A method of treating a human suffering from one or more conditions associated with one or more long-term complications of diabetes, the method comprising administering a composition comprising a compound that can bind or chelate oxidized copper in an amount effective to ameliorate one or more of said conditions.
- 26. A method of preventing tissue damage in a human associated with diabetes mellitus, which comprises the prophylactic administration to a human of a therapeutically effective amount of a compound that can bind or chelate oxidized copper.
- 31. A method of treating a human suffering from one or more conditions associated with one or more long-term complications of diabetes, the method comprising forming a cupric complex within the human by administering an effective amount of a copper binding agent.
- 36. A method of treating a human suffering from one or more conditions associated with one or more long-term complications of diabetes, the method comprising forming an oxidized copper complex within the human by administering an effective amount of a copper binding agent.
- 41. A method of preventing tissue damage in a human associated with diabetes mellitus, the method comprising forming a cupric complex within the human by prophylactically administering an effective amount of a copper binding agent.
- 46. A method of preventing tissue damage in a human associated with diabetes mellitus, the method comprising forming an oxidized copper complex within the human by prophylactically administering an effective amount of a copper binding agent.
Specification